IL22 and hepatocellular carcinoma: Their implication in HCC has not been studied yet even though IL-22 has been presented with controversial roles in hepatocytes, either promoting their regeneration (model of Con-A induced hepatitis) (66) or their proliferation in the diethyl-nitrosamine (DEN)-induced mouse HCC model (66–68).